Edwards Lifesciences

Location

70 route de l’Etraz 1260 Nyon

Switzerland

Google Maps Google Maps

About

Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring. Driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that enable them to save and enhance lives.

Edwards’ technologies are categorized into business units including, heart valve therapy, critical care, cardiac surgery systems and vascular, as well as transcatheter heart valves designed for non-surgical valve replacement.

Transcatheter aortic valve implantation (TAVI) enables multi-disciplinary heart teams to replace a patient's diseased aortic valve without traditional open-heart surgery and while the heart continues to beat - avoiding the need for cardiopulmonary bypass.

In Europe, Edwards SAPIEN transcatheter heart valves have been commercially available since 2007, and the next generation Edwards SAPIEN XT valve was approved in 2010. In November 2011, the Edwards SAPIEN valve became the first commercially approved transcatheter device enabling aortic valve replacement in the United States.

Related Videos

Seeing is Believing – The Edwards Mitral & Tricuspid Transcatheter…

Didier Tchétché, Philipp Lurz, Peter Lüdike, et al

Seeing is Believing: The Edwards Portfolio

Didier Tchétché Philipp Lurz Peter Lüdike Nicole Karam Andreas Rück Sam Dawkins Jorg Hausleiter Michael Böhm

Tips and Tricks in Imaging Your Patients With Valvular Heart Disease

Jose Luis Zamorano, Rebecca T Hahn, Patrizio Lancellotti, et al

EuroPCR 2021 Wrap-up: Mitral and Tricuspid Therapies

Nicolas M Van Mieghem, Philipp Lurz, Philip Raake, et al

Tips and Tricks in Imaging Your Patients With Valvular Heart Disease

Philippe Pibarot Patrizio Lancellotti Martin Swaans

A Peek into the Future – Repair and Replacement of the Mitral and…

Nicolas M Van Mieghem, Peter Lüdike, Philipp Lurz, et al

A Peek into the Future – Repair and Replacement of the Mitral and Tricuspid

Nicolas M Van Mieghem Peter Lüdike Philipp Lurz Ralph Stephan von Bardeleben Philip Raake

Related Articles

Transcatheter Aortic Valve Implantation in High-risk Patients with Severe…

Patricia Fonseca, Raphael Rosenhek, Vinayak Bapat, Markus Lins,

Measuring Aortic Valve Annulus Size for Transcatheter Aortic Valve…

Victoria Delgado, See Hooi Ewe, David Messika-Zeitoun, Jeroen J Bax, Alec Vahanian,